Skip to main navigation Skip to search Skip to main content

STARSCAPE-2 (EFC18327): A Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled Phase 3, Maintenance Study to Evaluate the Efficacy and Safety of Duvakitug in Participants with Moderately to Severely Active Crohn's Disease

Grants and Contracts Details

StatusActive
Effective start/end date9/8/26 → 9/8/28

Funding

  • Sanofi US Services Incorporated: $2.00